and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
CytomX Therapeutics Stock Price (Quote) NASDAQ:CTMX
$1.94 ( 5.43% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.59 | $2.00 | Tuesday, 5th Jul 2022 CTMX stock ended at $1.94. This is 5.43% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 8.29% from a day low at $1.81 to a day high of $1.96. |
| 90 days | $1.51 | $2.87 | |
| 52 weeks | $1.51 | $7.53 |
Historical CytomX Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $1.84 | $1.96 | $1.81 | $1.94 | 1 060 330 |
| 2022-07-01 | $1.89 | $1.91 | $1.84 | $1.84 | 451 721 |
| 2022-06-30 | $1.85 | $1.90 | $1.81 | $1.83 | 554 355 |
| 2022-06-29 | $1.85 | $1.99 | $1.80 | $1.87 | 730 275 |
| 2022-06-28 | $1.94 | $1.94 | $1.82 | $1.86 | 875 853 |
| 2022-06-27 | $1.90 | $2.00 | $1.86 | $1.94 | 1 543 215 |
| 2022-06-24 | $1.95 | $2.00 | $1.85 | $1.90 | 10 443 867 |
| 2022-06-23 | $1.80 | $1.88 | $1.78 | $1.87 | 833 470 |
| 2022-06-22 | $1.70 | $1.84 | $1.67 | $1.80 | 1 243 869 |
| 2022-06-21 | $1.64 | $1.74 | $1.61 | $1.71 | 909 365 |
| 2022-06-17 | $1.65 | $1.73 | $1.59 | $1.60 | 1 360 886 |
| 2022-06-16 | $1.70 | $1.70 | $1.59 | $1.65 | 756 796 |
| 2022-06-15 | $1.70 | $1.76 | $1.64 | $1.72 | 829 120 |
| 2022-06-14 | $1.77 | $1.77 | $1.66 | $1.69 | 361 104 |
| 2022-06-13 | $1.79 | $1.79 | $1.70 | $1.75 | 580 936 |
| 2022-06-10 | $1.88 | $1.89 | $1.79 | $1.86 | 734 427 |
| 2022-06-09 | $1.88 | $1.96 | $1.84 | $1.95 | 710 502 |
| 2022-06-08 | $1.90 | $2.00 | $1.89 | $1.91 | 782 453 |
| 2022-06-07 | $1.72 | $1.94 | $1.71 | $1.89 | 1 105 661 |
| 2022-06-06 | $1.78 | $1.86 | $1.73 | $1.74 | 1 217 029 |
| 2022-06-03 | $1.59 | $1.81 | $1.59 | $1.78 | 806 162 |
| 2022-06-02 | $1.57 | $1.62 | $1.52 | $1.58 | 435 256 |
| 2022-06-01 | $1.65 | $1.70 | $1.52 | $1.55 | 803 213 |
| 2022-05-31 | $1.62 | $1.67 | $1.59 | $1.61 | 512 603 |
| 2022-05-27 | $1.61 | $1.65 | $1.52 | $1.62 | 941 366 |
| 2022-05-26 | $1.54 | $1.58 | $1.51 | $1.57 | 530 635 |
| 2022-05-25 | $1.60 | $1.63 | $1.53 | $1.53 | 796 009 |
| 2022-05-24 | $1.56 | $1.63 | $1.52 | $1.60 | 774 668 |
| 2022-05-23 | $1.63 | $1.64 | $1.52 | $1.58 | 732 506 |
| 2022-05-20 | $1.70 | $1.74 | $1.56 | $1.62 | 648 392 |
| 2022-05-19 | $1.70 | $1.76 | $1.65 | $1.69 | 870 118 |
| 2022-05-18 | $1.82 | $1.83 | $1.68 | $1.69 | 921 437 |
| 2022-05-17 | $1.74 | $1.87 | $1.73 | $1.86 | 1 282 109 |
| 2022-05-16 | $1.75 | $1.82 | $1.71 | $1.73 | 662 300 |
| 2022-05-13 | $1.80 | $1.81 | $1.70 | $1.76 | 1 115 783 |
| 2022-05-12 | $1.62 | $1.78 | $1.62 | $1.74 | 1 020 370 |
| 2022-05-11 | $1.77 | $1.82 | $1.65 | $1.66 | 1 187 625 |
| 2022-05-10 | $1.57 | $1.83 | $1.55 | $1.78 | 2 634 583 |
| 2022-05-09 | $1.62 | $1.65 | $1.51 | $1.53 | 1 055 268 |
| 2022-05-06 | $1.69 | $1.72 | $1.53 | $1.62 | 901 909 |
| 2022-05-05 | $1.67 | $1.70 | $1.56 | $1.61 | 1 393 972 |
| 2022-05-04 | $1.72 | $1.73 | $1.59 | $1.71 | 1 290 519 |
| 2022-05-03 | $1.84 | $1.86 | $1.72 | $1.72 | 1 237 394 |
| 2022-05-02 | $1.71 | $1.83 | $1.71 | $1.82 | 2 388 281 |
| 2022-04-29 | $1.76 | $1.82 | $1.71 | $1.71 | 1 057 601 |
| 2022-04-28 | $1.82 | $1.86 | $1.71 | $1.79 | 3 385 021 |
| 2022-04-27 | $1.85 | $1.91 | $1.81 | $1.81 | 1 556 607 |
| 2022-04-26 | $1.96 | $2.00 | $1.84 | $1.85 | 1 001 930 |
| 2022-04-25 | $1.97 | $2.01 | $1.93 | $1.96 | 1 200 746 |
| 2022-04-22 | $2.02 | $2.09 | $1.95 | $1.99 | 920 600 |
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and Th... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
